Litcius/Paper detail

Vitamin D and Immunological Patterns of Allergic Diseases in Children

Agnieszka Lipińska‐Opałka, Agata Wawrzyniak, Jacek Z. Kubiak, Bolesław Kalicki

2021Nutrients26 citationsDOIOpen Access PDF

Abstract

Vitamin D, in addition to its superior role as a factor regulating calcium-phosphate metabolism, shows wide effects in other processes in the human body, including key functions of the immune system. This is due to the presence of vitamin D receptors in most cells of the human body. In our study, we aimed to assess whether there is a correlation between vitamin D content and the clinical course of allergic diseases as well as establish their immunological parameters in children. We found that vitamin D deficiency was significantly more frequent in the group of children with an allergic disease than in the control group (p = 0.007). Statistically significant higher vitamin D concentrations in blood were observed in the group of children with a mild course of the disease compared to children with a severe clinical course (p = 0.03). In the group of children with vitamin D deficiency, statistically significant lower percentages of NKT lymphocytes and T-regulatory lymphocytes were detected compared to the group of children without deficiency (respectively, p = 0.02 and p = 0.05), which highlights a potential weakness of the immune system in these patients. Furthermore, statistically higher levels of interleukin-22 were observed in the group of children with vitamin D deficiency (p = 0.01), suggesting a proinflammatory alert state. In conclusion, these results confirm the positive relationship between the optimal content of vitamin D and the lesser severity of allergic diseases in children, establishing weak points in the immune system caused by vitamin D deficiency in children.

Topics & Concepts

Vitamin D and neurologyImmune systemvitamin D deficiencyMedicineProinflammatory cytokineVitaminImmunologyDiseaseInternal medicinePhysiologyEndocrinologyInflammationVitamin D Research StudiesAsthma and respiratory diseasesIL-33, ST2, and ILC Pathways